Bactobio
PrivateLast Round
Convertible Debt
Dec 5, 2022
Total Funding Raised
$15.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bactobio is a biotechnology company that uses breakthroughs in genomics, machine learning, and bioengineering to culture previously unculturable microbes to discover novel antibiotics and sustainable plant protection solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bactobio Comparables
Compare Bactobio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hexagon Bio | 83% | |
| NovoBiotic Pharmaceuticals | 76% | |
| Biosortia Microbiomics | 73% |
Bactobio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Dec 5, 2022 | ||||
| Grant | Oct 25, 2022 | ||||
| Grant | Apr 1, 2022 | ||||
| Seed | Oct 6, 2021 | ||||
| Grant | May 1, 2021 | ||||
Pre Seed | Jul 1, 2020 |
Key People
Founding team and executive leadership
Bactobio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| UK Agri-Tech Centre | Seed |
| Entangle S.A. | Convertible Debt |
| Meltwind Advisory | Seed |
| Bridford Group | Convertible Debt |
| Innovate UK | Grant, Seed |
| Lendable | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 118% MoM, from 2.6K to 5.6K.
- Jan 1, 2026
First product commercialization planned for H1 2026.
Bactobio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bactobio's valuation, stock price, and market status.
Is Bactobio a public or private company?
Bactobio is a private company.
What is the current stock price of Bactobio?
Bactobio is a private company with no public stock price. No recent secondary market data is available.
How much is Bactobio worth (valuation)?
Valuation information for Bactobio is not publicly available.
Can I buy Bactobio stock?
Bactobio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bactobio's last funding round?
Bactobio's most recent funding round was Debt on December 5, 2022.
Who are the main investors in Bactobio?
Key investors in Bactobio include Bridford Group.
Will Bactobio IPO soon?
No public IPO plans have been announced for Bactobio.
How can I track Bactobio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bactobio's secondary market activity and sign up for updates.